COVID-19: the gendered impacts of the outbreak
暂无分享,去创建一个
[1] S. Lewin,et al. Between a shock and a hard place: challenges and developments in HIV latency reversal. , 2019, Current opinion in virology.
[2] C. Wenham,et al. Zika, abortion and health emergencies: a review of contemporary debates , 2019, Globalization and health.
[3] B. Walker,et al. Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting. , 2019, The lancet. HIV.
[4] Ting Yu,et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.
[5] B. Bennett,et al. A gendered human rights analysis of Ebola and Zika: locating gender in global health emergencies , 2016 .
[6] M. Johnson,et al. Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial , 2020, The Lancet.
[7] J. Eron,et al. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy , 2012, Nature.
[8] Laura Sochas,et al. Counting indirect crisis‐related deaths in the context of a low‐resilience health system: the case of maternal and neonatal health during the Ebola epidemic in Sierra Leone , 2017, Health policy and planning.
[9] João Nunes,et al. Gender mainstreaming as a pathway for sustainable arbovirus control in Latin America , 2020, PLoS neglected tropical diseases.
[10] S. Lewin,et al. Community and provider Community and provider perspectives on Treatment Interruptions in the landscape of HIV cure focused studies. , 2019, AIDS research and human retroviruses.
[11] 中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China./ 新型冠状病毒肺炎流行病学特征分析 , 2020 .
[12] China Cdc Weekly. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020 , 2020, China CDC weekly.
[13] S. Harman. Ebola, gender and conspicuously invisible women in global health governance , 2016 .
[14] Daniel I. S. Rosenbloom,et al. Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations. , 2015, The Journal of clinical investigation.
[15] Julia Smith. Overcoming the ‘tyranny of the urgent’: integrating gender into disease outbreak preparedness and response , 2019, Gender & Development.
[16] S. Lewin,et al. Barriers and strategies to achieve a cure for HIV. , 2018, The lancet. HIV.
[17] B. Walker. Faculty Opinions recommendation of A quantitative approach for measuring the reservoir of latent HIV-1 proviruses. , 2019, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[18] Yichong Li,et al. Prevalence and patterns of tobacco smoking among Chinese adult men and women: findings of the 2010 national smoking survey , 2016, Journal of Epidemiology & Community Health.
[19] D. Hazuda,et al. Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy , 2014, PLoS pathogens.
[20] G. Pantaleo,et al. The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo , 2015, PLoS pathogens.